New Delhi: Four of five people who have tested positive for coronavirus will get better on their own and there is no need for Indians to panic about the viral outbreak yet, says a leading Indian researcher and scientist.

Testing for the disease should also be done only when recommended, said Gagandeep Kang as the number of coronavirus cases in India rose to 30, including 16 Italian tourists as well as three patients in Kerala who have recovered.

"Please let public health authorities know about exposure to known infected persons or travel to areas where infections are known to be prevalent," the Christian Medical College professor, who last year became the first Indian woman to be elected fellow of the Royal Society in London, told.

Noting that all treatments are not curative but only supportive at the moment, she said four of five people will get better on their own and may need nothing more than drugs like paracetamol for fever and cough.

"The fifth person may need to see a doctor or be hospitalised. If you have breathing difficulty, you should see a doctor as soon as possible," said Kang, also vice-chair of the Norway-based International Coalition for Epidemic Preparedness Innovations (CEPI) that aims to derail epidemics by speeding up the development of vaccines.

"For everyone, there is no need to worry too much or panic. We are exposed to viruses every day. Make sure you wash your hands well, wipe down or use disinfectants on surfaces. Avoid touching your face," she said.

The coronavirus (CoV) is a large family of viruses that causes illnesses ranging from the common cold to acute respiratory syndromes. COVID-19 that has killed over 3,000 people worldwide and infected more than 90,000 is a novel strain not seen before.

Over 53,000 people have recovered from the infection globally, according to an interactive map compiled by the Johns Hopkins Center for Systems Science and Engineering.

The World Health Organisation has already declared the outbreak a "global emergency", stopping short of terming it a pandemic.

Nose and throat swabs are used as specimens for detecting the coronavirus.

The test takes at least 12-24 hours for the confirmation. It a gene-based assay called polymerase chain reaction (PCR) and a more sensitive form called reverse-transcription polymerase chain reaction (RTPCR).

According to Kang, known for her inter-disciplinary research studying the transmission, development and prevention of intestinal infections, there are still more cases of flu in India and around the world than of the COVID-19.

"This is important to know and understand. It looks like this infection causes diseases that are more severe than the flu, but less severe than Severe acute respiratory syndrome (SARS)," she said.

SARS is a viral respiratory illness caused by a coronavirus called SARS-associated coronavirus (SARS-CoV).

At the moment, it seems that COVID-19, unlike the flu, does not cause severe disease in children.

"It does, however, cause more severe disease in the elderly, and in people who have cardiovascular disease, hypertension and diabetes," said Kang, who was awarded the prestigious Infosys Prize in Life Sciences in 2016.

She said many drugs against the viral infection are being tested, including vaccines which may be ready by next year.

"There are currently no vaccines, but there are many in development. If all goes well with vaccine development efforts we might have a vaccine next year. But vaccine candidates do not always succeed," she said.

Kang emphasised that people must inform public health authorities if they suspect they have been exposed to the virus.

She also advised people to work from home if they have a fever and a cough.

"Stay six-10 feet away from people who are coughing or sneezing," she said.

"Remember that with most respiratory viruses, most people exposed and sick with relatively minor symptoms recover and have some protection against reinfection," she said.

Kang added that with the novel coronavirus, getting infected does not mean that every infected person will be severely ill.

The scientist is also executive director of the Translational Health Science and Technology Institute (THSTI), an autonomous institution of the Department of Biotechnology.

 

Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.



Bengaluru (PTI): Bannerghatta Biological Park on Monday announced the successful import of eight black-capped capuchin monkeys from a wildlife facility in South Africa under an animal exchange programme.

The four male and four female monkeys (Sapajus apella) were imported from the Induna Primate and Parrot Park in South Africa and arrived at the Kempegowda International Airport at around 9 pm on December 14, BBP said in a statement.

The exchange, carried out under a duly approved animal exchange programme, aims to strengthen conservation initiatives, enhance genetic diversity of the captive population, promote visitor awareness, and support scientific research, the statement said.

According to BBP officials, the import was conducted in strict compliance with all statutory and regulatory requirements.

ALSO READ: Bomb threat at Mangaluru RTO turns out to be hoax

Prior approvals were obtained from the Central Zoo Authority, New Delhi, along with no-objection certificates from the State Chief Wildlife Warden, the Ministry of Environment, Forest and Climate Change, the Department of Animal Husbandry and Dairying, and the Wildlife Crime Control Bureau.

Import permits were also secured from the Directorate General of Foreign Trade (DGFT) in accordance with guidelines prescribed by the Department of Animal Husbandry, officials said.

"All animals were inspected and quarantined in South Africa as per the prescribed guidelines. In addition, advance no-objection certificates were obtained from the Animal Quarantine Services before importation," the statement said.

Upon arrival, the capuchins were placed in a designated quarantine facility and will undergo post-import health checks before being moved to the zoo premises for public display, officials said.

"This initiative underscores Bannerghatta Biological Park’s continued commitment to global conservation collaboration, scientific animal management, and compliance with national and international wildlife regulations," the statement added.

The exchange programme further strengthens BBP’s role in promoting best practices in ex-situ conservation and wildlife education.